Cargando…
Endocrine therapy combined with targeted therapy in hormone receptor-positive metastatic breast cancer
Increasing numbers of targeted drugs are used in hormone receptor (HR)-positive metastatic breast cancer (MBC) to overcome or delay resistance to endocrine therapy. This study will systemically review the progress made in endocrine therapy combined with targeted therapy in the treatment of HR-positi...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546887/ https://www.ncbi.nlm.nih.gov/pubmed/32852380 http://dx.doi.org/10.1097/CM9.0000000000000923 |